Victor Marchione, MD, FCCP
Victor L. Marchione, M.D., F.C.C.P.
BOARD CERTIFICATIONS: INTERNAL & PULMONARY MEDICINE
Medical Director
(1999 - present)
IQuit SMOKING PROGRAM
Smoking Consulation Service
Medical Consultant
(2005 - present)
Palisade Medical Center
Smoking Cessation Program
Medical Director
(2000 - 2003)

Clinical Research Division
Health Integrated Services

Medical Director
(2001 - 2003)
Hudson Rehabilitation Therapy
Medical Consultant
(1999 - 2003)
Advanced Respiratory (Vest)
Director of Clinical Services
(2001 - 2003)
Institute for Better Breathing
600 Pavonia Avenue, Jersey City, New Jersey 07306

 

 CERTIFICATIONS
 
1980
Dottore di Medicina
1984
Diplomat American Board of Internal Medicine
1987
Diplomat American Board of Pulmonary Medicine
1988
Fellow American College of Chest Physicians
   
 MEDICAL LICENSURE
 
1980
New Jersey
1983
New York
   
 HOSPITAL
 AFFILIATIONS
 
1985 - Present
Christ Hospital — Jersey City, New Jersey 07306
2005 - Present
Palisades Medical Center — 7600 River Road, NB, NJ 07047
1985 - 2003
Meadowlands Hospital — Secaucus, New Jersey 07094
1985 - 1988
St. Francis Hospital — 25 McWilliams Place, Jersey City, New Jersey 07302
1985 - 1997
Greenville Hospital — 1825 Kennedy Blvd., Jersey City, New Jersey 07304
1998 - 2000
Jersey City Medical Center — Jersey City, New Jersey 07305
   
 APPOINTMENTS
 
1987 - 1990
Co-Director Pulmonary Medicine — Christ Hospital, Jersey City, New Jersey
1988 - 1991
Disaster Committee — Christ Hospital, Jersey City, New Jersey
1988 - 1990
ICU Committee — Christ Hospital, Jersey City, New Jersey
1990 - 1993
Pharmacy Committee — Christ Hospital, Jersey City, New Jersey
1991 - 1995
Critical Care Committee — St. Francis Hospital, Jersey City, New Jersey
1992 - 1995
Credential Committee — Christ Hospital, Jersey City, New Jersey
1993 - 1995
Director of Pulmonary Medicine — St. Francis Hospital, Jersey City, New Jersey
1996 - 2000
Medical Director — Pavonia Medical Associates, Jersey City, North Bergen - Secaucus,
New Jersey
1998 - 2003
Director Clinical Research — Jersey Integrated Health, Jersey City - North Bergen - Secaucus,
New Jersey
   
 EDUCATION
 
1973
B.S., Jersey City State College, New Jersey
1981
M.D., University of Messina, Messina, Italy
   
 TRAINING
 
1980 - 1981
Internship (PGY-1) Medicine — Mountainside Hospital, Montclair, New Jersey
1981 - 1983
Residency (PGY-2, PGY-3) Medicine — St. Michael’s Hospital, Newark, New Jersey
1983 - 1985
Fellowship (PGY-4, PGY-5) Pulmonary Medicine — New York Medical College,
Westchester Medical Center, Valhalla, New York
   
 LECTURES
 
1994
Ventilator Management — Christ Hospital, Jersey City, New Jersey
1995
COPD Update — St. Francis Hospital, Jersey City, New Jersey
1996
Lung Reduction Surgery — St. Francis Hospital, Jersey City, New Jersey
1997
Antibiotics in the Critical Care Setting — Greenville Hospital, Jersey City, New Jersey
2001- 02
High Frequency Chest Wall Oscillating Vest/COPD — Scottsdale, Arizona; Hilton Head,
South Carolina
2001
ACCP Meeting — Smoking Cessation and Practice Revenues, San Francisco, California
2002
New York State Thoracic Society — Smoking Cessation, West Point, New York
2004
CME Lecture — Evidence-Based Smoking Cessation Protocols, Christ Hospital, New Jersey
2004
CME Lecture — Compliance with Federal Guidelines in the Treatment of Tobacco Addiction, Palisade Medical Centre, North Bergen, NJ
2005
Lecture Series — Current Trends in Asthma Therapy, Schering Plough
   
 MEDIA
 
1997
ABC News and World Report — Smoking Cessation
1998
CBS Evening News with Dan Rather — Smoking Cessation
1999
NBC Today Show — I Quit Smoking Cessation Program
2001
COPD Satellite Media Tour — Sponsored by Novartis, November 13
2001
Video News Release COPD/FORADIL — Sponsored by Novartis
2005
Chairperson, Inauguration Ceromony — I Quit Smoking Clinic, Palisade Medical Center, NB, NJ. Key note speaker US Senator Frank Lautenberg (D-NJ).
   
 CONSULTANCY
 

1999 - 2002

Advanced Respiratory (Vest)

1999 - 2002

Transworld Health
2001 - 2003
Therapro
2005 - 2006
Wyeth Laboratories
2005 - 2006
Palisade General Medical Center
   
 CLINICAL RESEARCH
 

  Principal Investigator
  (See Appendix A)

  Appendix A
  Clinical Research

 
   
1999
The Effect of Zyban vs. Placebo as an Aid to Smoking Reduction. Sponsored by GlaxoWellcome.
1999
Randomized, Double-Blind, Double-Dummy, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Oral Augmentin SR 2000/125mg Twice Daily for 7 Days Oral Clarithromycin 500mg Twice Daily for 7 Days in the Treatment of Acute Exacerbation of Chronic Bronchitis. Sponsored by Smithkline.  
1999
Open, Non-Comparative, Multicenter Study to Assess the Efficacy and Safety of Oral Augmentin SR1750-125mg Twice Daily for 7 or 14 Days for the Treatment of Bacterial Community Acquired Pneumonia in Adults. Sponsored by SmithKline (SB-2500/547)
2000

Multi-Center, Multinational Open Clinical Study to Explore Relationships between Genotypic and Serologic Findings and Phenotypic Manifestations in a Large Cohort of Participants. Sponsored by  Genomics Collaborative  (99-302/99-303) 2000

2000
Double-Blind, Randomized, Placebo-Controlled Surveillance Study of Asthma Event Outcomes in Subjects Receiving Either Usual Pharmacotherapy of Asthma or Usual Pharmacotherapy Plus Salmeterol 42 MCG Twice Daily. Sponsored by GlaxoWellcome (SMART)
2000
Short Term Assessment of the Effects of High Frequency Chest Wall Oscillation on the Pulmonary Function and Quality of Life of Patients with COPD. Sponsorsed by American Biosystems, Inc. (ABI VEST)
2001
High Frequency Chest Wall Oscillation in COPD Patients  in a 90-Day Study. Sponsored by American Biosystems, Inc. (ABI VEST)
2001
Multicenter, Double-Blind, Randomized Study to Compare The Safety and  Efficacy of Levofloxacin 750mg Once Daily for Five Days vs. Levofloxacin 500mg Once Daily for 10 Days in the Treatment of Mild to Severe Community Acquired Pneumonia in Adults. Sponsored by Ortho-McNeil  (CAPS 150)
2001
Multicenter, Open-Label, Non-Comparative Study to Evaluate the Safety and Efficacy of Levofloxacin Once Daily for Five Days in the Treatment of Mild to Severe Community-Acquired Pneumonia Adults. (CAPS 171) Sponsored by Ortho-McNeill
2001
Randomized, Blinded Trial Studying the Efficacy and Safety pg High-Dose 750 mg. Short-Course (3-5 days) Levofloxacin Therapy in Uncomplicated and Complicated Acute Bacterial Exacerbation of Chronic Bronchitis.
2001
Prospective, Randomized, Open-Label, Multicenter Comparison of the Efficacy and Safety of Sequential Treatment with Intravenous (IV) Oral (PO) Moxifloxacin +-IV/PO Azithromycin  +- IV/PO Metronidazole Followed by Cefuroxime axetil PO +-PO Azithromycin +-PO Metronidazole in Patients with Community or Nursing Home Acquired Pneumonia.
   
 RECIPIENT of GRANTS:
 
2003
Sepracor Pharmaceuticals
Surveillance of NJ Ground-Zero workers.
2003
Merck Pharmaceuticals
Surveillance of NJ Ground-Zero workers.
2007
Pfizer Pharmaceuticals
CME GRANT, Establish Centers of Excellence in Diagnosing and Treating Tobacco Addiction
2008
Dey Pharmaceuticals
CME GRANT, Outreach Program to Underserved Populations to Treat Tobacco Addiction
   
 ROUNDTABLE:
 
Guest Panelist Guest Panelist: State of the Art Conference Series.
Medical Communications and Delivery of Health Care.
Sponsored by Stevens Institute of Technology, Hoboken, NJ
S. Vincent Grasso, Coordinator
7/11/07 Medical Information and Strategies in Healthcare Delivery
Enhancing the Delivery of Healthcare Services to an Aging U.S. Population
9/19/07 Enhancing the Efficiency and Effectiveness of Multimodal Messaging within the Delivery of Healthcare.
10/31/07 Strategies to Enhance the Management of non Hospital-based asthmatic and COPD patient.